Similarly, among the 793 men with localized prostate cancer and 54 with metastatic disease, the inverse association between serum IGF‐1 level and risk of metastatic disease was no longer significant after adjustment for biopsy GS (Ptrend = 0.079; Table S6). The gene discussed is IGF1; the disease is metastatic neoplasm.